Three doses of Pfizer’s vaccines have 80% efficacy in children younger than five
Covid vaccines have played a massive role in bringing back the pre-pandemic world. In an attempt to protect kids, Pfizer and BioNTech have asked the FDA to authorize three doses of their vaccines for children between 6 months and five years. Children under five are advised to take a three microgram dose, which is just a tenth of the 30 microgram shot administered to adults. Pfizer’s study shows that the three doses of their vaccines have 80% efficacy in children younger than five years. Pfizer’s claims will be reviewed by FDA’s Vaccines and related Biological Products Advisory Committee.
Pfizer CEO Albert Bourla has stated that the vaccine has been studied on thousands of children and was well tolerated and produced a robust immune response in them. The interim results from the trial also show that the vaccine was 80% effective against the Omicron Variant. They are also bound to submit their findings to the European Medicines Agency and other regulatory authorities worldwide. A study conducted by Kaiser Family Foundation revealed that only 18% of the parents were okay with their child being vaccinated, and 38% of the parents preferred to wait and see how the vaccine was tolerated by children who had taken them.
